JPMorgan Chase & Co. Lowers U.S. Physical Therapy (NYSE:USPH) Price Target to $110.00

U.S. Physical Therapy (NYSE:USPH) had its price objective reduced by JPMorgan Chase & Co. from $120.00 to $110.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 42.73% from the company’s previous close.

A number of other equities analysts also recently weighed in on USPH. William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Barrington Research cut their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th. JMP Securities assumed coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 price target for the company. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Finally, StockNews.com cut U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $109.00.

U.S. Physical Therapy Trading Up 1.2 %

Shares of NYSE:USPH traded up $0.90 during midday trading on Wednesday, reaching $77.07. The company’s stock had a trading volume of 4,413 shares, compared to its average volume of 98,214. The firm has a market cap of $1.17 billion, a price-to-earnings ratio of 81.71, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. The business has a 50 day moving average price of $85.69 and a 200 day moving average price of $87.25. U.S. Physical Therapy has a 1 year low of $75.84 and a 1 year high of $113.63. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to analysts’ expectations of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. Research analysts forecast that U.S. Physical Therapy will post 2.67 EPS for the current year.

Insider Activity

In other news, COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares of the company’s stock, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of institutional investors have recently added to or reduced their stakes in the company. HighTower Advisors LLC increased its position in shares of U.S. Physical Therapy by 2.5% during the fourth quarter. HighTower Advisors LLC now owns 4,833 shares of the company’s stock worth $429,000 after acquiring an additional 119 shares during the last quarter. CBIZ Investment Advisory Services LLC increased its holdings in U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after purchasing an additional 122 shares during the last quarter. Albert D Mason Inc. raised its position in shares of U.S. Physical Therapy by 1.3% in the 4th quarter. Albert D Mason Inc. now owns 10,596 shares of the company’s stock valued at $940,000 after purchasing an additional 139 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in shares of U.S. Physical Therapy by 1.0% during the 4th quarter. Harbor Capital Advisors Inc. now owns 16,344 shares of the company’s stock valued at $1,450,000 after buying an additional 156 shares during the last quarter. Finally, Aquatic Capital Management LLC grew its position in shares of U.S. Physical Therapy by 18.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock worth $115,000 after buying an additional 198 shares in the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.